After the COVID-19 outbreak, increasing number of patients worldwide who have survived
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …

Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a
reduction in lung compliance and capacity. The development of PF is relatively rare, but it …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …

Introduction; Pulmonary fibrosis is a frequently reported COVID-19 sequela in which the
exact prevalence and risk factors are yet to be established. This meta-analysis aims to …

Clinical characteristics and outcomes of post-COVID-19 pulmo... : Medicine Clinical
characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study …

Patients with coronavirus disease 2019 (COVID-19) usually suffer from post-acute sequelae
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long …

SARS-COV-2 has created one of the most massive pandemics in modern history. There is a
rapid accumulation of data on its epidemiology, clinical course, diagnosis, management …

Since December 2019, coronavirus disease (COVID‐19) has rapidly swept the world. So far,
more than 30 million people have been infected and nearly one million have died. Although …

At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions
worldwide with a high mortality rate due to a lack of definitive treatment. Despite having a …